A study assessed yerba maté for its potential effects on weight loss, obesity-related biochemical markers, and the regulation of fat tissue gene expression in obese mice induced by diet. The findings showed that yerba maté treatment significantly reduced weight gain and fat accumulation, decreased epididymal fat-pad weight, and restored serum cholesterol, triglycerides, LDL cholesterol, and glucose levels. Yerba maté is known for its biological activities linked to its high polyphenol content, particularly chlorogenic acid, which influences glucose metabolism and lowers cardiovascular disease risk by reducing LDL and cholesterol oxidation. The results align with previous research indicating that yerba maté enhances glucose tolerance in obese animals. Additionally, methylxanthines and saponins in yerba maté contribute to its pharmacological effects, including interference with cholesterol metabolism. The compounds in yerba maté extract may work together to reduce body weight gain, visceral fat, and serum cholesterol, triglycerides, LDL cholesterol, and glucose levels.

Adipose tissue functions as an endocrine organ crucial for metabolism and homeostasis. The secretion of adipokines affects insulin sensitivity, glucose metabolism, inflammation, and atherosclerosis, linking excess fat to diabetes and cardiovascular diseases. A study found that high-fat diets regulated the expression of several genes in adipose tissue, and yerba maté extract treatment restored these gene expressions.

Obesity is linked to chronic low-grade inflammation characterized by abnormal cytokine production in white adipose tissue (WAT). Increased inflammatory cytokines contribute to obesity-related inflammation and metabolic disorders. TNF-α is a key cytokine that raises IL-6 levels, influencing glucose transport and lipid metabolism. In obese individuals, TNF-α and IL-6 levels are elevated, and reducing fat mass lowers these levels. TNF-α also affects leptin secretion, with higher body fat correlating with increased leptin levels. The reduction in adipose mass after yerba maté treatment may explain the observed anti-inflammatory effects.

Obesity also leads to macrophage accumulation through the CCL2/CCR2 pathway, producing pro-inflammatory molecules linked to obesity-induced inflammation. The expression of CCL2 and CCR2 rises with obesity. The data suggests that yerba maté extract treatment reduces macrophage infiltration, thereby lowering adipose tissue inflammation.

Chronic inflammation from excess fat is associated with obesity-related health issues. PAI-1, an inhibitor of tissue plasminogen activator, is linked to cardiovascular disease and correlates positively with visceral fat. Weight loss reduces PAI-1 activity in obese individuals, and TNF-α regulates PAI-1 expression. Yerba maté extract may inhibit atherosclerosis progression by restoring PAI-1 mRNA levels, linked to decreased visceral fat and TNF-α downregulation.

Hypertension often accompanies obesity, with a positive correlation between blood pressure and angiotensinogen levels. In animal studies, increased angiotensinogen mRNA in WAT led to hypertension and higher fat mass. Yerba maté supplementation reduced angiotensinogen levels, suggesting potential protection against hypertension.

Adiponectin, the most abundant adipokine in WAT, has insulin-sensitizing effects and is decreased in obese individuals. Weight loss increases circulating adiponectin levels, and yerba maté extract supplementation can restore adiponectin mRNA levels.

Adipogenesis is the process where stem cells become mature adipocytes, with PPARγ as a key regulator. In a study, PPAR-γ2 mRNA levels were reduced in high-fat diet-fed mice. Chronic high-fat diet exposure appears to limit fat storage expansion. Yerba maté extract treatment restored PPAR-γ2 mRNA levels.

Unlike WAT, brown adipose tissue (BAT) uses lipids for thermogenesis. BAT has high mitochondrial numbers and small lipid droplets. PGC-1α, a coactivator of PPARγ, stimulates mitochondrial biogenesis. UCP-1 expression in BAT is crucial for energy expenditure, and its dysfunction is linked to obesity. High-fat diets decrease PGC-1α and UCP-1 expression in BAT. Yerba maté treatment restored these mRNA levels, likely due to its methylxanthine content.

In conclusion, studies indicate that yerba maté extract has significant anti-obesity effects in living organisms and modulates the expression of several obesity-related genes.